Profile
| Metric | Value |
|---|---|
| Full Name | Relmada Therapeutics, Inc. |
| Ticker | NASDAQ: RLMD |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | relmada.com |
| Employees | 17 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $3.96 | |
| Price, 1D Change | +3.94% | |
| $290M | ||
| - | ||
| - | ||
| 0.84 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.65 | ||
| EPS, 1Y Change | +19.22% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:4 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.65 | ||
| EPS Estimate | -$0.83 | |
| EPS Est. Change | +68.70% | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $3.96 | |
| Price Target | - | $9.00 |
| Price Tgt. Change | - | +127.27% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.28 | -$3.28 | -0.07% | |
| -$1.72 | -$2.65 | -54.16% | |
| -$0.83 | N/A | +68.70% | |
| -$0.36 | N/A | +86.42% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $3.96 | |
| $1.82 | ||
| SMA 200 vs Price | -54.10% | |
| $4.17 | ||
| SMA 50 vs Price | +5.21% | |
| 0.84 | ||
| $0.34 | ||
| 46.82 | ||
| 57.56% | ||
| 151.44% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$2.65 | ||
| $0.00 | ||
| - | ||
| -$83.89M | ||
| - | ||
| -$79.98M | ||
| - | ||
| -$83.89M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 4.45 | ||
| 4.45 | ||
| - | ||
| - | ||
| -7.77 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 30.68 | ||
| -4.78 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $35.52M | ||
| $44.91M | ||
| $45.82M | ||
| $45.80M | ||
| $10.30M | ||
| $10.29M | ||
| $0.00 | ||
| $0.00 | ||
| $4.13M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $79.98M | ||
| $83.89M | ||
| $0.00 | ||
| $37.72M | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$51.76M | ||
| $51.56M | ||
| -$40.30K | ||
| $0.00 | ||
| -$51.76M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Jefferies | ||
| Mizuho | → | |
| Mizuho | → | |
| Leerink Partners | → | |
| Goldman Sachs | → | |
| Mizuho | → | |
| SVB Leerink | ||
| Guggenheim | → | |
| Goldman Sachs | → | |
| Oppenheimer | → |
Analyst sentiment
Institutional ownership
Screeners with RLMD
FAQ
What is the ticker symbol for Relmada Therapeutics, Inc.?
The ticker symbol for Relmada Therapeutics, Inc. is NASDAQ:RLMD
Does Relmada Therapeutics, Inc. pay dividends?
No, Relmada Therapeutics, Inc. does not pay dividends
What sector is Relmada Therapeutics, Inc. in?
Relmada Therapeutics, Inc. is in the Healthcare sector
What industry is Relmada Therapeutics, Inc. in?
Relmada Therapeutics, Inc. is in the Biotechnology industry
What country is Relmada Therapeutics, Inc. based in?
Relmada Therapeutics, Inc. is headquartered in United States
When did Relmada Therapeutics, Inc. go public?
Relmada Therapeutics, Inc. initial public offering (IPO) was on June 20, 2014
Is Relmada Therapeutics, Inc. in the S&P 500?
No, Relmada Therapeutics, Inc. is not included in the S&P 500 index
Is Relmada Therapeutics, Inc. in the NASDAQ 100?
No, Relmada Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Relmada Therapeutics, Inc. in the Dow Jones?
No, Relmada Therapeutics, Inc. is not included in the Dow Jones index
When was Relmada Therapeutics, Inc. last earnings report?
Relmada Therapeutics, Inc.'s most recent earnings report was on November 13, 2025
When does Relmada Therapeutics, Inc. report earnings?
The next expected earnings date for Relmada Therapeutics, Inc. is March 26, 2026
Data Sources & References
- RLMD Official Website www.relmada.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1553643/000121390025109983/0001213900-25-109983-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1553643/000101376225003426/0001013762-25-003426-index.htm
- RLMD Profile on Yahoo Finance finance.yahoo.com/quote/RLMD
- RLMD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rlmd